Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovex International (INVX) Change in Accured Expenses (2017 - 2025)

Innovex International (INVX) has disclosed Change in Accured Expenses for 17 consecutive years, with $860000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses fell 73.61% year-over-year to $860000.0, compared with a TTM value of -$19.1 million through Dec 2025, down 3030.11%, and an annual FY2025 reading of -$19.1 million, down 3030.11% over the prior year.
  • Change in Accured Expenses was $860000.0 for Q4 2025 at Innovex International, up from -$7.6 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $15.9 million in Q3 2023 and bottomed at -$25.1 million in Q1 2022.
  • Average Change in Accured Expenses over 5 years is -$604700.0, with a median of $628000.0 recorded in 2022.
  • The sharpest move saw Change in Accured Expenses surged 11092.04% in 2022, then tumbled 1031.34% in 2025.
  • Year by year, Change in Accured Expenses stood at $113000.0 in 2021, then soared by 11092.04% to $12.6 million in 2022, then tumbled by 146.37% to -$5.9 million in 2023, then skyrocketed by 155.58% to $3.3 million in 2024, then crashed by 73.61% to $860000.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for INVX at $860000.0 in Q4 2025, -$7.6 million in Q3 2025, and $9.6 million in Q2 2025.